Reliance Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 13 Jan 2017 72.08 0.19
(0.26%)

NAV High-Low (in Rs)

ONE Mth 1499.76
1499.76
52-WEEk 1408.45
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - - 17.32
Sensex 2.1 3.01 -1.97 11.59 28.32
Nifty 2.15 3.36 -1.51 13.11 33.14

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid 7.00 (Rs) 29-02-2016
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Dec 2016
Category Share (%)
Cash & Cash Equivalent 0.00
CBLO 0.69
Equity 99.63
› More
   As On 31 Dec 2016
Sector Name Amount
Finance & Investments 3.83
Healthcare 5.58
Miscellaneous 6.79
NA 0.69
Pharmaceuticals - Indian - Bulk Drugs 16.06
Pharmaceuticals - Indian - Bulk Drugs & Formln 48.89
Pharmaceuticals - Multinational 18.48
› More
   As On 31 Dec 2016
Company Name
Abbott India 10.91
Aurobindo Pharma 8.93
Sun Pharma.Inds. 8.61
Divi's Lab. 8.13
Lupin 7.93
Cipla 7.58
Sanofi India 7.57
Cadila Health. 7.37
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Capital Asset Management Company,

One Indiabulls Centre Tower 1
12th Flr 841 Senapati Bapat
Marg Elphinstone Road Mumbai-400013

Phone: 022-30994600 | Fax: 022-30994699

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com